A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancer

✍ Scribed by Timothy A. Shepherd; Louis N. Jungheim; Damon L. Meyer; James J. Starling

• Book ID: 108477098
• Publisher: Elsevier Science
• Year: 1991
• Tongue: English
• Weight: 425 KB
• Volume: 1
• Category: Article
• ISSN: 0960-894X
• DOI: 10.1016/s0960-894x(01)81083-0